Want to join the conversation?
During 1Q16, $USB's non-interest expense was $2.7Bil, an increase of $84MM or 3.2% vs. 1Q15. The increase from a year ago was primarily due to increased compensation expense, professional services expense, and technology and communications expense. This was partially offset by lower employee benefits and other non-interest expense.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.